Clinical Trial Update: A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of rucaparib in patients with metastatic castration-resistant prostate cancer and homologous recombination gene deficiency has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Rucaparib (rucaparib)

Snippet

Sponsor: pharmaand GmbH | Conditions: Metastatic Castration Resistant Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2022-06-08